Several years ago, drug maker Gilead Science Inc. applied for a Chinese patent for the use of Remdesivir against coronaviruses. Remdesivir was originally intended to treat Ebola but was also shown to inhibit coronaviruses, such as SARS.
Recently, scientists at the government-run Wuhan Institute of Virology, along with a military laboratory, reportedlyapplied to patent the use of Remdesivir to treat the specific coronavirus, Covid-19, which is being blamed for the recent outbreak.
No decision has been made regarding the Gilead patent application. However, if approved, as a member of the WTO, the Chinese government may be able to use the TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement to obtain a compulsory licence for Remdesivir. If so, the Chinese government would decide, subject to any appeal, what payment Gilead would receive.
In considering the Wuhan Institute’s application, the Chinese patent office will likely have to consider issues of anticipation and obviousness.
For its part, Gilead is helping end the current crisis by working with health authorities. The company is reportedly providing Remdesivir for emergency use in clinical trials.
In vitro studies of Remdesivir and chloroquine have been published in Cell Research, stating that the mixture is effective for inhibiting Covid-19.
As reported by Reuters, three former employees of Taiwan Semiconductor Manufacturing Company ("TSMC") were charged with violating security law and other offences in Taiwan. The prosecutors have…
As reported by Reuters, the 9th US Circuit Court of Appeals has reinstated an $81 million award against Boeing, in a suit brought by Zunum Aero, an aircraft startup, accusing Boeing of stealing trade…
As reported by Mason Hayes & Curran, the Federal Court of Australia has reportedly found the supermarket chain, Aldi, liable for copyright infringement regarding illustrations used on the…
Carnegie Hall has reportedly commenced an action against Carnegie Diner and Café for trademark infringement.In its complaint filed with the United States District Court, Southern District of New York…
In Bell Canada et al. v. Millennium Funding, Inc. et al., 2025 FCA 153, Bell Canada and Bell Aliant (collectively, “Bell”) appealed an order granting the Respondents’ (collectively, “Millenium…
Goyard, the Parisian brand established in 1853 and still privately owned, has reportedly faced a surge in counterfeit bags flooding the market. The company refrains from advertising, avoids e-commerce…
